BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2506 related articles for article (PubMed ID: 25881008)

  • 1. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
    Peng J; Chen YT; Chen CL; Li L
    Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
    Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dansylation isotope labeling liquid chromatography mass spectrometry for parallel profiling of human urinary and fecal submetabolomes.
    Su X; Wang N; Chen D; Li Y; Lu Y; Huan T; Xu W; Li L; Li L
    Anal Chim Acta; 2016 Jan; 903():100-9. PubMed ID: 26709303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Isotope Labeling LC-MS for Human Blood Metabolome Analysis.
    Han W; Li L
    Methods Mol Biol; 2018; 1730():213-225. PubMed ID: 29363075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of strategies for untargeted urinary metabolomic analysis using gas chromatography-mass spectrometry.
    Khodadadi M; Pourfarzam M
    Metabolomics; 2020 May; 16(6):66. PubMed ID: 32419109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
    Shen W; Han W; Li Y; Meng Z; Cai L; Li L
    Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short review of applications of liquid chromatography mass spectrometry based metabolomics techniques to the analysis of human urine.
    Zhang T; Watson DG
    Analyst; 2015 May; 140(9):2907-15. PubMed ID: 25756251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative metabolomic profiling using dansylation isotope labeling and liquid chromatography mass spectrometry.
    Zhou R; Li L
    Methods Mol Biol; 2014; 1198():127-36. PubMed ID: 25270927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Coverage Quantitative Metabolomics of Human Urine: Effects of Freeze-Thaw Cycles on the Urine Metabolome and Biomarker Discovery.
    Chen D; Chan W; Zhao S; Li L; Li L
    Anal Chem; 2022 Jul; 94(27):9880-9887. PubMed ID: 35758637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting human urinary metabolome by LC-MS/MS: a review.
    Rodríguez-Morató J; Pozo ÓJ; Marcos J
    Bioanalysis; 2018 Apr; 10(7):489-516. PubMed ID: 29561651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming Sample Matrix Effect in Quantitative Blood Metabolomics Using Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry.
    Chen D; Han W; Su X; Li L; Li L
    Anal Chem; 2017 Sep; 89(17):9424-9431. PubMed ID: 28787119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods used to increase the comprehensive coverage of urinary and plasma metabolomes by MS.
    Chen Y; Xu J; Zhang R; Abliz Z
    Bioanalysis; 2016 May; 8(9):981-97. PubMed ID: 27079429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid-liquid extraction combined with differential isotope dimethylaminophenacyl labeling for improved metabolomic profiling of organic acids.
    Peng J; Li L
    Anal Chim Acta; 2013 Nov; 803():97-105. PubMed ID: 24216202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Application of Ultra-Performance Liquid Chromatography-TOF MS for Precision Large Scale Urinary Metabolic Phenotyping.
    Lewis MR; Pearce JT; Spagou K; Green M; Dona AC; Yuen AH; David M; Berry DJ; Chappell K; Horneffer-van der Sluis V; Shaw R; Lovestone S; Elliott P; Shockcor J; Lindon JC; Cloarec O; Takats Z; Holmes E; Nicholson JK
    Anal Chem; 2016 Sep; 88(18):9004-13. PubMed ID: 27479709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry.
    Hušek P; Švagera Z; Hanzlíková D; Řimnáčová L; Zahradníčková H; Opekarová I; Šimek P
    J Chromatogr A; 2016 Apr; 1443():211-32. PubMed ID: 27012787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study.
    Zhang T; Watson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counting missing values in a metabolite-intensity data set for measuring the analytical performance of a metabolomics platform.
    Huan T; Li L
    Anal Chem; 2015 Jan; 87(2):1306-13. PubMed ID: 25496403
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 126.